Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients.
Bencsik
Krisztina
K
Fricska-Nagy
Zsanett
Z
Rajda
Cecília
C
Füvesi
Judit
J
Török
Margit
M
Vécsei
László
L
Csépány
Tünde
T
Mátyás
Klotild
K
Dobos
Eniko
E
Rózsa
Csilla
C
Semjén
Judit
J
D000328:Adult; D018450:Disease Progression; D004334:Drug Administration Schedule; D005260:Female; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D006814:Hungary; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000191:economics; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D055502:Secondary Prevention
D007155:Immunologic Factors